ARF6 and breast cancer: Moreover, Morishige et al. showed that GEP100/BRAG2, an ARF6 GEF, is expressed in 70% of primary breast ductal carcinomas and contributes to the invasive behavior of MDA-MB-231 BC cells (Morishige et al., 2008).